IM Cannabis evaluates selling assets in Germany and Israel to focus on the US
IM Cannabis' decision comes after an executive order by Donald Trump that accelerates the reclassification of marijuana in the North American territory
Published on 12/31/2025
IM Cannabis Corp. announced on Tuesday (30) that it has hired financial advisors to structure its potential entry into the United States market. The new strategic guideline includes evaluating the sale of its current operations in Germany and Israel.
This decision by IM Cannabis is a direct response to the executive order signed by President Donald Trump on December 18, 2025. The document mandated the acceleration of the cannabis reclassification process in the country.
To lead this transition, the company has appointed the firm SSC Advisors. The consultancy will be responsible for identifying sector entry opportunities for IM Cannabis and seeking buyers for the current assets.
Regulatory Impact on IM Cannabis
The recent presidential order instructed the Attorney General to expedite the change of marijuana from Schedule I to Schedule III in the Controlled Substances Act. This amendment would facilitate commercial operations and medical research, benefiting medicinal cannabis companies.
The organization stated that it will monitor federal regulatory developments in the United States. Meanwhile, IM Cannabis continues to evaluate the options presented by the financial consultancy.
IM Cannabis Financial Challenges
Currently valued at $7.24 million, IM Cannabis faces an accumulated debt of $12.62 million. Additionally, the company recorded a negative EBITDA of $2.24 million in the last twelve months. Market data shows that IM Cannabis shares have depreciated by over 44% in the last semester.
So far, IM Cannabis' business model has been based on importing and distributing products for medical patients. The company operates pharmacies and online platforms in Israel, as well as maintaining the subsidiary Adjupharm GmbH in Germany.
In an official statement regarding the operational history, the company declared: "The Company has focused its resources on achieving sustainable and profitable growth in its highest value markets, Israel and Germany".
